e-Nicotine Technology Information

e-Nicotine Technology (eNT) is the first healthcare company to provide smokers with a new choice for their health – smoking cessation without nicotine cessation. eNT helps smokers transition from cigarettes to safe nicotine delivery while avoiding withdrawal and satisfying their nicotine cravings. eNT’s nicotine delivery device is being developed under the new regulatory pathway created by the Center for Tobacco Products at the FDA, enabling a significantly de-risked rapid-to-market strategy. Smoking remains the leading cause of preventable death, killing 440,000 Americans annually. Despite the dangers of smoking, approximately 1-in-5 Americans still smoke, and while 85% of them want to quit, only 5% will succeed in their quit attempt. The commercial market produced by this nicotine dependency is over $80B in the U.S. alone. The three founders of the company have significant experience in starting companies, raising capital, and moving forward products to the clinic and FDA approval. The management team has world-class expertise in aerosolization and pulmonary deposition of drug, addiction, nicotine cravings, commercial scale-up of medical devices, and mobile e-health applications.